|
Volumn 15, Issue SUPPL. 1, 2008, Pages 1-21
|
The German guideline for the management of hepatitis B virus infection: Short version
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR DIPIVOXIL;
ANTIVIRUS AGENT;
ENTECAVIR;
LAMIVUDINE;
PEGINTERFERON ALPHA2A;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
TELBIVUDINE;
TENOFOVIR DISOPROXIL;
ALCOHOL CONSUMPTION;
ALGORITHM;
ANTIVIRAL THERAPY;
BONE MARROW TRANSPLANTATION;
DELTA AGENT HEPATITIS;
DIAGNOSTIC TEST;
DIALYSIS;
DISEASE COURSE;
DRUG EFFICACY;
DRUG SUBSTITUTION;
DRUG USE;
EVALUATION;
FOLLOW UP;
GENE MUTATION;
GENETIC VARIABILITY;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS DELTA VIRUS;
HISTOLOGY;
IMMUNOPROPHYLAXIS;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY DYSFUNCTION;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
MIXED INFECTION;
PREGNANCY;
PRIORITY JOURNAL;
REVIEW;
STEM CELL TRANSPLANTATION;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
TREATMENT RESPONSE;
VACCINATION;
ADOLESCENT;
CHILD;
DRUG RESISTANCE, VIRAL;
FEMALE;
GERMANY;
HEPATITIS B;
HEPATITIS B VACCINES;
HEPATITIS B VIRUS;
HUMANS;
LIVER TRANSPLANTATION;
MALE;
VACCINATION;
|
EID: 49849094760
PISSN: 13520504
EISSN: 13652893
Source Type: Journal
DOI: 10.1111/j.1365-2893.2008.01013.x Document Type: Review |
Times cited : (29)
|
References (2)
|